Viking Global Investors
GRCL

Viking Global Investors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Viking Global Investors’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-491,647
Closed -$2.97M – 118
2021
Q4 		$2.97M Sell
491,647
-866,212
-64% -$5.23M 0.01% 107
2021
Q3 		$18.8M Buy
1,357,859
+27,531
+2% +$382K 0.05% 93
2021
Q2 		$17.3M Sell
1,330,328
-14,748
-1% -$192K 0.05% 86
2021
Q1 		$20.7M Buy
+1,345,076
New +$20.7M 0.06% 86